TY - JOUR
T1 - Adult acute lymphocytic leukemia
T2 - Future research directions
AU - Kantarjian, H. M.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - This article reviews future research of potential benefits to adults with acute lymphocytic leukemia (ALL). This new research includes dose intensive anthracyclines, novel agents, STI571 for Philadelphia chromosome-positive ALL, and risk-oriented strategies.
AB - This article reviews future research of potential benefits to adults with acute lymphocytic leukemia (ALL). This new research includes dose intensive anthracyclines, novel agents, STI571 for Philadelphia chromosome-positive ALL, and risk-oriented strategies.
UR - http://www.scopus.com/inward/record.url?scp=0035098480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035098480&partnerID=8YFLogxK
U2 - 10.1016/S0889-8588(05)70205-7
DO - 10.1016/S0889-8588(05)70205-7
M3 - Article
C2 - 11253607
AN - SCOPUS:0035098480
SN - 0889-8588
VL - 15
SP - 207
EP - 211
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
IS - 1
ER -